At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 44 enrolled
Drug / intervention
Survivor-only progressive walking and resistance exercise +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dyadic Exercise Intervention for Cancer Survivors and Caregivers
In Brief
A Phase 1 clinical trial evaluating Survivor-only progressive walking and resistance exercise and Dyadic progressive walking and resistance exercise for Cancer. Completed, enrolled 44 participants across 1 site.
Detailed Summary
The purpose of the study is to see whether exercise can improve the health and well-being of cancer survivors. We also want to know about the health and well being of caregivers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedJun 2013
Primary CompletionMay 2015
Study CompletionAug 2015
TodayJul 2026
First PostedJun 21, 2013
Enrollment StartMay 1, 2013
Primary CompletionMay 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 13.0 years ago
Interventions
Survivor-only progressive walking and resistance exercisebehavioral
Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor only
Dyadic progressive walking and resistance exercisebehavioral
Daily, home-based, tailored exercise program delivered over the course of 6 weeks to the survivor and caregiver as a dyad